The following is an excerpt.
When will whole human genome sequencing hit the long-sought-after $1,000 mark? How will scientists bear the interpretation challenges? Can a patient be trusted with their own genomic data?
As the din of debate on the utility, price, andethics of human genomics grows louder, the techniques are already being incorporated into everyday routine operations in health care. Clinical genetics labs—which continue to make next-generation sequencing (NGS) technologies higher throughput and more accurate for a lower cost—have already launched a first foray of lab-developed tests that use genomics data to diagnose a variety of diseases. Labs estimate cost savings of 10 to 50 times over complex genetic tests, with turn-around times of days and weeks rather than weeks and months.
View the original ariticle here: Opinion: Genomics in the Clinic
